Report cover image

Global Hepatitis A Vaccine Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 191 Pages
SKU # APRC20284091

Description

Summary

According to APO Research, The global Hepatitis A Vaccine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Hepatitis A Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Hepatitis A Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Hepatitis A Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Hepatitis A Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Hepatitis A Vaccine include GSK, Zhejiang Pukang, Changchun Institute of Biological, IMBCAMS, Sanofi, Merck, Convac, Sinovac and KM Biologics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Hepatitis A Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Hepatitis A Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Hepatitis A Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hepatitis A Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Hepatitis A Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Hepatitis A Vaccine sales, projected growth trends, production technology, application and end-user industry.

Hepatitis A Vaccine Segment by Company

GSK
Zhejiang Pukang
Changchun Institute of Biological
IMBCAMS
Sanofi
Merck
Convac
Sinovac
KM Biologics
Hepatitis A Vaccine Segment by Type

Inactivated Vaccine
Live Attenuated Vaccine
Hepatitis A Vaccine Segment by Application

Government Institution
Private Sector
Other
Hepatitis A Vaccine Segment by Region

North America
United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis A Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hepatitis A Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis A Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Hepatitis A Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatitis A Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Hepatitis A Vaccine Market by Type
1.2.1 Global Hepatitis A Vaccine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Hepatitis A Vaccine Market by Application
1.3.1 Global Hepatitis A Vaccine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Hepatitis A Vaccine Market Dynamics
2.1 Hepatitis A Vaccine Industry Trends
2.2 Hepatitis A Vaccine Industry Drivers
2.3 Hepatitis A Vaccine Industry Opportunities and Challenges
2.4 Hepatitis A Vaccine Industry Restraints
3 Global Market Growth Prospects
3.1 Global Hepatitis A Vaccine Revenue Estimates and Forecasts (2020-2031)
3.2 Global Hepatitis A Vaccine Revenue by Region
3.2.1 Global Hepatitis A Vaccine Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Hepatitis A Vaccine Revenue by Region (2020-2025)
3.2.3 Global Hepatitis A Vaccine Revenue by Region (2026-2031)
3.2.4 Global Hepatitis A Vaccine Revenue Market Share by Region (2020-2031)
3.3 Global Hepatitis A Vaccine Sales Estimates and Forecasts 2020-2031
3.4 Global Hepatitis A Vaccine Sales by Region
3.4.1 Global Hepatitis A Vaccine Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Hepatitis A Vaccine Sales by Region (2020-2025)
3.4.3 Global Hepatitis A Vaccine Sales by Region (2026-2031)
3.4.4 Global Hepatitis A Vaccine Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Hepatitis A Vaccine Revenue by Manufacturers
4.1.1 Global Hepatitis A Vaccine Revenue by Manufacturers (2020-2025)
4.1.2 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Hepatitis A Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Hepatitis A Vaccine Sales by Manufacturers
4.2.1 Global Hepatitis A Vaccine Sales by Manufacturers (2020-2025)
4.2.2 Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Hepatitis A Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Hepatitis A Vaccine Sales Price by Manufacturers (2020-2025)
4.4 Global Hepatitis A Vaccine Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Hepatitis A Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Hepatitis A Vaccine Manufacturers, Product Type & Application
4.7 Global Hepatitis A Vaccine Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Hepatitis A Vaccine Market CR5 and HHI
4.8.2 2024 Hepatitis A Vaccine Tier 1, Tier 2, and Tier 3
5 Hepatitis A Vaccine Market by Type
5.1 Global Hepatitis A Vaccine Revenue by Type
5.1.1 Global Hepatitis A Vaccine Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Hepatitis A Vaccine Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Hepatitis A Vaccine Revenue Market Share by Type (2020-2031)
5.2 Global Hepatitis A Vaccine Sales by Type
5.2.1 Global Hepatitis A Vaccine Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Hepatitis A Vaccine Sales by Type (2020-2031) & (K Units)
5.2.3 Global Hepatitis A Vaccine Sales Market Share by Type (2020-2031)
5.3 Global Hepatitis A Vaccine Price by Type
6 Hepatitis A Vaccine Market by Application
6.1 Global Hepatitis A Vaccine Revenue by Application
6.1.1 Global Hepatitis A Vaccine Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Hepatitis A Vaccine Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Hepatitis A Vaccine Revenue Market Share by Application (2020-2031)
6.2 Global Hepatitis A Vaccine Sales by Application
6.2.1 Global Hepatitis A Vaccine Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Hepatitis A Vaccine Sales by Application (2020-2031) & (K Units)
6.2.3 Global Hepatitis A Vaccine Sales Market Share by Application (2020-2031)
6.3 Global Hepatitis A Vaccine Price by Application
7 Company Profiles
7.1 GSK
7.1.1 GSK Comapny Information
7.1.2 GSK Business Overview
7.1.3 GSK Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 GSK Hepatitis A Vaccine Product Portfolio
7.1.5 GSK Recent Developments
7.2 Zhejiang Pukang
7.2.1 Zhejiang Pukang Comapny Information
7.2.2 Zhejiang Pukang Business Overview
7.2.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Zhejiang Pukang Hepatitis A Vaccine Product Portfolio
7.2.5 Zhejiang Pukang Recent Developments
7.3 Changchun Institute of Biological
7.3.1 Changchun Institute of Biological Comapny Information
7.3.2 Changchun Institute of Biological Business Overview
7.3.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio
7.3.5 Changchun Institute of Biological Recent Developments
7.4 IMBCAMS
7.4.1 IMBCAMS Comapny Information
7.4.2 IMBCAMS Business Overview
7.4.3 IMBCAMS Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 IMBCAMS Hepatitis A Vaccine Product Portfolio
7.4.5 IMBCAMS Recent Developments
7.5 Sanofi
7.5.1 Sanofi Comapny Information
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Sanofi Hepatitis A Vaccine Product Portfolio
7.5.5 Sanofi Recent Developments
7.6 Merck
7.6.1 Merck Comapny Information
7.6.2 Merck Business Overview
7.6.3 Merck Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Merck Hepatitis A Vaccine Product Portfolio
7.6.5 Merck Recent Developments
7.7 Convac
7.7.1 Convac Comapny Information
7.7.2 Convac Business Overview
7.7.3 Convac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Convac Hepatitis A Vaccine Product Portfolio
7.7.5 Convac Recent Developments
7.8 Sinovac
7.8.1 Sinovac Comapny Information
7.8.2 Sinovac Business Overview
7.8.3 Sinovac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Sinovac Hepatitis A Vaccine Product Portfolio
7.8.5 Sinovac Recent Developments
7.9 KM Biologics
7.9.1 KM Biologics Comapny Information
7.9.2 KM Biologics Business Overview
7.9.3 KM Biologics Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 KM Biologics Hepatitis A Vaccine Product Portfolio
7.9.5 KM Biologics Recent Developments
8 North America
8.1 North America Hepatitis A Vaccine Market Size by Type
8.1.1 North America Hepatitis A Vaccine Revenue by Type (2020-2031)
8.1.2 North America Hepatitis A Vaccine Sales by Type (2020-2031)
8.1.3 North America Hepatitis A Vaccine Price by Type (2020-2031)
8.2 North America Hepatitis A Vaccine Market Size by Application
8.2.1 North America Hepatitis A Vaccine Revenue by Application (2020-2031)
8.2.2 North America Hepatitis A Vaccine Sales by Application (2020-2031)
8.2.3 North America Hepatitis A Vaccine Price by Application (2020-2031)
8.3 North America Hepatitis A Vaccine Market Size by Country
8.3.1 North America Hepatitis A Vaccine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Hepatitis A Vaccine Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Hepatitis A Vaccine Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Hepatitis A Vaccine Market Size by Type
9.1.1 Europe Hepatitis A Vaccine Revenue by Type (2020-2031)
9.1.2 Europe Hepatitis A Vaccine Sales by Type (2020-2031)
9.1.3 Europe Hepatitis A Vaccine Price by Type (2020-2031)
9.2 Europe Hepatitis A Vaccine Market Size by Application
9.2.1 Europe Hepatitis A Vaccine Revenue by Application (2020-2031)
9.2.2 Europe Hepatitis A Vaccine Sales by Application (2020-2031)
9.2.3 Europe Hepatitis A Vaccine Price by Application (2020-2031)
9.3 Europe Hepatitis A Vaccine Market Size by Country
9.3.1 Europe Hepatitis A Vaccine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Hepatitis A Vaccine Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Hepatitis A Vaccine Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Hepatitis A Vaccine Market Size by Type
10.1.1 China Hepatitis A Vaccine Revenue by Type (2020-2031)
10.1.2 China Hepatitis A Vaccine Sales by Type (2020-2031)
10.1.3 China Hepatitis A Vaccine Price by Type (2020-2031)
10.2 China Hepatitis A Vaccine Market Size by Application
10.2.1 China Hepatitis A Vaccine Revenue by Application (2020-2031)
10.2.2 China Hepatitis A Vaccine Sales by Application (2020-2031)
10.2.3 China Hepatitis A Vaccine Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Hepatitis A Vaccine Market Size by Type
11.1.1 Asia Hepatitis A Vaccine Revenue by Type (2020-2031)
11.1.2 Asia Hepatitis A Vaccine Sales by Type (2020-2031)
11.1.3 Asia Hepatitis A Vaccine Price by Type (2020-2031)
11.2 Asia Hepatitis A Vaccine Market Size by Application
11.2.1 Asia Hepatitis A Vaccine Revenue by Application (2020-2031)
11.2.2 Asia Hepatitis A Vaccine Sales by Application (2020-2031)
11.2.3 Asia Hepatitis A Vaccine Price by Application (2020-2031)
11.3 Asia Hepatitis A Vaccine Market Size by Country
11.3.1 Asia Hepatitis A Vaccine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Hepatitis A Vaccine Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Hepatitis A Vaccine Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Hepatitis A Vaccine Market Size by Type
12.1.1 SAMEA Hepatitis A Vaccine Revenue by Type (2020-2031)
12.1.2 SAMEA Hepatitis A Vaccine Sales by Type (2020-2031)
12.1.3 SAMEA Hepatitis A Vaccine Price by Type (2020-2031)
12.2 SAMEA Hepatitis A Vaccine Market Size by Application
12.2.1 SAMEA Hepatitis A Vaccine Revenue by Application (2020-2031)
12.2.2 SAMEA Hepatitis A Vaccine Sales by Application (2020-2031)
12.2.3 SAMEA Hepatitis A Vaccine Price by Application (2020-2031)
12.3 SAMEA Hepatitis A Vaccine Market Size by Country
12.3.1 SAMEA Hepatitis A Vaccine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Hepatitis A Vaccine Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Hepatitis A Vaccine Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Hepatitis A Vaccine Value Chain Analysis
13.1.1 Hepatitis A Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Hepatitis A Vaccine Production Mode & Process
13.2 Hepatitis A Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Hepatitis A Vaccine Distributors
13.2.3 Hepatitis A Vaccine Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.